BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37020384)

  • 1. Rolipram suppresses migration and invasion of human choriocarcinoma cells by inhibiting phosphodiesterase 4-mediated epithelial-mesenchymal transition.
    Huang Y; Zheng Y; Wang Q; Qi C
    J Biochem Mol Toxicol; 2023 Jul; 37(7):e23363. PubMed ID: 37020384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4.
    Kolosionek E; Savai R; Ghofrani HA; Weissmann N; Guenther A; Grimminger F; Seeger W; Banat GA; Schermuly RT; Pullamsetti SS
    Mol Biol Cell; 2009 Nov; 20(22):4751-65. PubMed ID: 19759179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
    Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
    PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant-like profile and reduced sensitivity to rolipram in mice deficient in the PDE4D phosphodiesterase enzyme.
    Zhang HT; Huang Y; Jin SL; Frith SA; Suvarna N; Conti M; O'Donnell JM
    Neuropsychopharmacology; 2002 Oct; 27(4):587-95. PubMed ID: 12377395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: comparison with rolipram.
    Dlaboga D; Hajjhussein H; O'Donnell JM
    Brain Res; 2006 Jun; 1096(1):104-12. PubMed ID: 16730340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling.
    Li YF; Cheng YF; Huang Y; Conti M; Wilson SP; O'Donnell JM; Zhang HT
    J Neurosci; 2011 Jan; 31(1):172-83. PubMed ID: 21209202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration.
    Elnagdy M; Wang Y; Rodriguez W; Zhang J; Bauer P; Wilkey DW; Merchant M; Pan J; Farooqui Z; Cannon R; Rai S; Maldonado C; Barve S; McClain CJ; Gobejishvili L
    J Pathol; 2023 Nov; 261(3):361-371. PubMed ID: 37735782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PDE4 pathway inhibition in rat experimental stroke.
    Yang F; Sumbria RK; Xue D; Yu C; He D; Liu S; Paganini-Hill A; Fisher M
    J Pharm Pharm Sci; 2014; 17(3):362-70. PubMed ID: 25224348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.
    Ribeiro ASF; Fernandes VS; Martínez-Sáenz A; Martínez P; Barahona MV; Orensanz LM; Blaha I; Serrano-Margüello D; Bustamante S; Carballido J; García-Sacristán A; Prieto D; Hernández M
    J Sex Med; 2014 Apr; 11(4):930-941. PubMed ID: 24754330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIF-1α contributes to metastasis in choriocarcinoma by regulating DEC1 expression.
    Xu Y; Ren B; Wang M
    Clin Transl Oncol; 2023 Jun; 25(6):1641-1649. PubMed ID: 36575343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.
    Campos-Toimil M; Keravis T; Orallo F; Takeda K; Lugnier C
    Br J Pharmacol; 2008 May; 154(1):82-92. PubMed ID: 18311187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
    Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
    Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4.
    Gobejishvili L; Barve S; Breitkopf-Heinlein K; Li Y; Zhang J; Avila DV; Dooley S; McClain CJ
    J Pharmacol Exp Ther; 2013 Oct; 347(1):80-90. PubMed ID: 23887098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase-4 inhibition reduces ECLS-induced vascular permeability and improves microcirculation in a rodent model of extracorporeal resuscitation.
    Wollborn J; Siemering S; Steiger C; Buerkle H; Goebel U; Schick MA
    Am J Physiol Heart Circ Physiol; 2019 Mar; 316(3):H751-H761. PubMed ID: 30681364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of phosphodiesterase 4 inhibitor and serum on migration of endotoxin-stimulated macrophages.
    Yang JX; Hsiung TC; Weng FC; Ding SL; Wu CP; Conti M; Chuang TH; Catherine Jin SL
    Innate Immun; 2018 Nov; 24(8):501-512. PubMed ID: 30409089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model.
    Tsunoda T; Ota T; Fujimoto T; Doi K; Tanaka Y; Yoshida Y; Ogawa M; Matsuzaki H; Hamabashiri M; Tyson DR; Kuroki M; Miyamoto S; Shirasawa S
    Mol Cancer; 2012 Jul; 11():46. PubMed ID: 22830422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterus-relaxing effect of β2-agonists in combination with phosphodiesterase inhibitors: studies on pregnant rat in vivo and on pregnant human myometrium in vitro.
    Verli J; Klukovits A; Kormányos Z; Hajagos-Tóth J; Ducza E; Seres AB; Falkay G; Gáspár R
    J Obstet Gynaecol Res; 2013 Jan; 39(1):31-9. PubMed ID: 22765375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF.
    Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R
    Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.
    Terry R; Cheung YF; Praestegaard M; Baillie GS; Huston E; Gall I; Adams DR; Houslay MD
    Cell Signal; 2003 Oct; 15(10):955-71. PubMed ID: 12873709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.